grants_govHT942526ERPLRA
Open
DoW Epilepsy Leveraging Research Award
- Response deadline
- Aug 17, 2026 Closed
- Date posted
- May 21, 2026
- Source
- Open notice
Description
Summary: The intent of the fiscal year 2026 (FY26) Epilepsy Research Program (ERP) Leveraging Research Award is to support basic, translational and/or clinical research that repurposes or expands existing research resources to accelerate the understanding of post-traumatic epilepsy (PTE) and associated comorbidities. Distinctive Features: The study must adapt an existing cohort, resource, research tool, or intervention for which PTE was not a prior focus or application. **NEW for FY26** An investigator may be named on only one FY26 ERP Leveraging Research Award application as a Principal Investigator.
Classifications
- NAICS12.420
Documents (1)
- DownloadHT942526ERPLRA_GG.pdfapplication/pdf694 KB
Contacts
- help@ebrap.org301-619-1139
Similar contracts
- DoW Breast Cancer, Clinical Research Extension AwardDue Nov 18, 2026
- DoW Breast Cancer, Breakthrough Award Levels 1 and 2Due Nov 18, 2026
- DoW Reconstructive Transplant, Investigator-Initiated Research AwardDue Nov 4, 2026
- DoW Neurofibromatosis Synergistic Idea AwardDue Sep 22, 2026
- DoW Neurofibromatosis Investigator-Initiated Research AwardDue Sep 22, 2026
- DoW Neurofibromatosis Exploration-Hypothesis Development AwardDue Sep 22, 2026